Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03334617
Title Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy (HUDSON)
Acronym HUDSON
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | AUT

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Fullerton California 92835 United States Details
Research Site La Jolla California 92093 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site Washington District of Columbia 20016 United States Details
Research Site Chicago Illinois 60637 United States Details
Research Site Baltimore Maryland 21224 United States Details
Research Site Baltimore Maryland 21287 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site New York New York 10032 United States Details
Research Site Philadelphia Pennsylvania 19111 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Nashville Tennessee 37212 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Fairfax Virginia 22031 United States Details
Research Site Innsbruck 6020 Austria Details
Research Site Salzburg 5020 Austria Details
Research Site Wien 1140 Austria Details
Research Site Wien 1210 Austria Details
Research Site Edmonton Alberta T6G 1Z2 Canada Details
Research Site Brampton Ontario L6R 3J7 Canada Details
Research Site Ottawa Ontario K1H 8L6 Canada Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Montreal Quebec H2X 3E4 Canada Details
Research Site Bordeaux 33076 France Details
Research Site Nantes Cedex 1 44093 France Details
Research Site Paris 75877 France Details
Research Site Villejuif 94800 France Details
Research Site Berlin 12203 Germany Details
Research Site Esslingen a.N. 73730 Germany Details
Research Site Grosshansdorf 22927 Germany Details
Research Site Heidelberg 69126 Germany Details
Research Site Köln 50924 Germany Details
Research Site Haifa 31096 Israel Details
Research Site Kfar Saba 95847 Israel Details
Research Site Petah Tikva 49100 Israel Details
Research Site Ramat Gan 5265601 Israel Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 6351 Korea, Republic of Details
Research Site Barcelona 08036 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Sevilla 41009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field